IT1306171B1 - Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2- - Google Patents

Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-

Info

Publication number
IT1306171B1
IT1306171B1 IT1999RM000465A ITRM990465A IT1306171B1 IT 1306171 B1 IT1306171 B1 IT 1306171B1 IT 1999RM000465 A IT1999RM000465 A IT 1999RM000465A IT RM990465 A ITRM990465 A IT RM990465A IT 1306171 B1 IT1306171 B1 IT 1306171B1
Authority
IT
Italy
Prior art keywords
methyl
pharmaceutical composition
hydroxybenzoic acid
polymer
hcl3o2
Prior art date
Application number
IT1999RM000465A
Other languages
English (en)
Inventor
Wiktor Djaczenko
Djaczenko Maria Strumillo
Danila Fava
Original Assignee
Wiktor Djaczenko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wiktor Djaczenko filed Critical Wiktor Djaczenko
Priority to IT1999RM000465A priority Critical patent/IT1306171B1/it
Publication of ITRM990465A0 publication Critical patent/ITRM990465A0/it
Priority to AU64688/00A priority patent/AU6468800A/en
Priority to AT00951845T priority patent/ATE264125T1/de
Priority to DE60009933T priority patent/DE60009933D1/de
Priority to CA002379653A priority patent/CA2379653A1/en
Priority to EP00951845A priority patent/EP1218063B8/en
Priority to PCT/IT2000/000309 priority patent/WO2001005387A2/en
Publication of ITRM990465A1 publication Critical patent/ITRM990465A1/it
Application granted granted Critical
Publication of IT1306171B1 publication Critical patent/IT1306171B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT1999RM000465A 1999-07-21 1999-07-21 Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2- IT1306171B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT1999RM000465A IT1306171B1 (it) 1999-07-21 1999-07-21 Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
AU64688/00A AU6468800A (en) 1999-07-21 2000-07-21 Pharmaceutical composition for topical application, uses and process for the preparation thereof
AT00951845T ATE264125T1 (de) 1999-07-21 2000-07-21 Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung
DE60009933T DE60009933D1 (de) 1999-07-21 2000-07-21 Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung
CA002379653A CA2379653A1 (en) 1999-07-21 2000-07-21 Pharmaceutical composition for topical application, uses and process for the preparation thereof
EP00951845A EP1218063B8 (en) 1999-07-21 2000-07-21 Pharmaceutical composition containing trichloroacetic acid, 2-oh benzoic acid and menthol for topical application and process for the preparation thereof
PCT/IT2000/000309 WO2001005387A2 (en) 1999-07-21 2000-07-21 Pharmaceutical composition containing trichloroacetic acid, 2-oh benzoic and menthol for topical application, uses and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000465A IT1306171B1 (it) 1999-07-21 1999-07-21 Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-

Publications (3)

Publication Number Publication Date
ITRM990465A0 ITRM990465A0 (it) 1999-07-21
ITRM990465A1 ITRM990465A1 (it) 2001-01-21
IT1306171B1 true IT1306171B1 (it) 2001-05-30

Family

ID=11406895

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000465A IT1306171B1 (it) 1999-07-21 1999-07-21 Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-

Country Status (7)

Country Link
EP (1) EP1218063B8 (it)
AT (1) ATE264125T1 (it)
AU (1) AU6468800A (it)
CA (1) CA2379653A1 (it)
DE (1) DE60009933D1 (it)
IT (1) IT1306171B1 (it)
WO (1) WO2001005387A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20090269390A1 (en) * 2008-04-25 2009-10-29 Medtronic, Inc. Medical devices, polymers, compositions, and methods for delivering a haloacetate
ES2758349T3 (es) * 2010-07-15 2020-05-05 Progressare Medinvest B V Composición para el tratamiento de lesiones de la piel y/o de las uñas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059441A1 (de) * 1981-03-02 1982-09-08 Füssener Textil AG Bioaktives Mittel auf Terpen/alpha-Ketocarbonsäure-Basis
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
DE3622089A1 (de) * 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung

Also Published As

Publication number Publication date
EP1218063B8 (en) 2004-09-22
CA2379653A1 (en) 2001-01-25
ITRM990465A0 (it) 1999-07-21
EP1218063A2 (en) 2002-07-03
AU6468800A (en) 2001-02-05
ITRM990465A1 (it) 2001-01-21
WO2001005387A3 (en) 2001-09-13
DE60009933D1 (de) 2004-05-19
WO2001005387A2 (en) 2001-01-25
ATE264125T1 (de) 2004-04-15
EP1218063B1 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
EE03137B1 (et) Veterinaarravim ja protsess selle valmistamiseks
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
GEP20043314B (en) Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa
MY132705A (en) Novel compounds with analgesic effect
CA2396111A1 (en) Substances for use in treating psoriasis
SE0102440D0 (sv) New compound
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
IT1306171B1 (it) Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
IS1771B (is) Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
BR0011880A (pt) Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
HUP0204324A2 (en) Use of fsh for preparation of pharmaceutical composition suitable for treating infertility
IT1318556B1 (it) Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
DE69830176D1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
BR0111852A (pt) Nova interferona para o tratamento de esclerose múltipla
AR009446A1 (es) Utilizacion del acido 2-(3,4-dimetoxinamoil)aminobenzoico (tranilast) en la fabricacion de un medicamento para el tratamiento o prevencion de larestenosis, composicion farmaceutica y procedimiento de preparacion.
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
DE60202299D1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten